Figure 3From: Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: analysis of two Phase I, randomised, double-blind, placebo-controlled studies Effects of AZD9164 on mean values for FEV 1 over the first 4 h after dosing. A. FEV1 0–4 h after first dose – GMAD, JMAD combined data from healthy subjects. B. FEV1 0–4 h after last dose – GMAD, JMAD combined data from healthy subjects.Back to article page